Published in Neurology on August 28, 2012
Current practices in feeding tube placement for US acute ischemic stroke inpatients. Neurology (2014) 1.56
Estimating and communicating prognosis in advanced neurologic disease. Neurology (2013) 0.96
Variation in do-not-resuscitate orders for patients with ischemic stroke: implications for national hospital comparisons. Stroke (2014) 0.90
Influence of acute complications on outcome 3 months after ischemic stroke. PLoS One (2013) 0.79
The lack of documentation of preferences in a cohort of adults who died after ischemic stroke. Neurology (2016) 0.75
Thrombolytic treatment for in-hospital ischemic strokes in United States. J Vasc Interv Neurol (2014) 0.75
End-of-life decisions in acute stroke patients: an observational cohort study. BMC Palliat Care (2016) 0.75
Today's Approach to Treating Brain Swelling in the Neuro Intensive Care Unit. Semin Neurol (2016) 0.75
Critical appraisal of advance directives given by patients with fatal acute stroke: an observational cohort study. BMC Med Ethics (2017) 0.75
Neurologic Examination at 24 to 48 Hours Predicts Functional Outcomes in Basilar Artery Occlusion Stroke. Stroke (2016) 0.75
Early transition to comfort measures only in acute stroke patients: Analysis from the Get With The Guidelines-Stroke registry. Neurol Clin Pract (2017) 0.75
Palliative Care for Hospitalized Patients With Stroke: Results From the 2010 to 2012 National Inpatient Sample. Stroke (2017) 0.75
Predictive accuracy of physicians' estimates of outcome after severe stroke. PLoS One (2017) 0.75
The unintended consequences of publicly reporting quality information. JAMA (2005) 6.55
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Developing physician communication skills for patient-centered care. Health Aff (Millwood) (2010) 3.45
Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke (2004) 2.42
Do-not-resuscitate orders and predictive models after intracerebral hemorrhage. Neurology (2010) 1.97
Hospital spending and inpatient mortality: evidence from California: an observational study. Ann Intern Med (2011) 1.79
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program. Circulation (2010) 1.66
Mortality as a measure of quality: implications for palliative and end-of-life care. JAMA (2007) 1.57
Absolutely no hope? Some ambiguity of futility of care in devastating acute stroke. Crit Care Med (2004) 1.54
Prognosis and decision making in severe stroke. JAMA (2005) 1.36
Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med (2010) 1.19
Palliative care consultations in hospitalized stroke patients. J Palliat Med (2010) 1.19
Causes of mortality on a university hospital neurology service. Neurologist (2006) 0.91
Public reporting of quality data for stroke: is it measuring quality? Stroke (2008) 0.85
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord (2004) 4.83
Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68
Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients. Crit Care Med (2007) 2.76
A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74
Financial anatomy of neuroscience research. Ann Neurol (2006) 2.71
Financing of U.S. biomedical research and new drug approvals across therapeutic areas. PLoS One (2009) 1.55
Health state preferences and decision-making after malignant middle cerebral artery infarctions. Neurology (2010) 1.52
An approach to evaluating the therapeutic misconception. IRB (2009) 1.35
Evidence, preferences, recommendations--finding the right balance in patient care. N Engl J Med (2012) 1.26
Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 1.17
The evolving role and value of libraries and librarians in health care. JAMA (2013) 1.07
The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation. Med Decis Making (2007) 1.03
Symptomatic and palliative care for stroke survivors. J Gen Intern Med (2012) 1.02
Development and testing of the Parkinson's disease quality of life scale. Mov Disord (2003) 1.01
Research participants' "irrational" expectations: common or commonly mismeasured? IRB (2013) 1.00
Treatment decisions after severe stroke: uncertainty and biases. Stroke (2012) 1.00
CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes. Radiology (2002) 0.99
Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model. J Womens Health (Larchmt) (2009) 0.97
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology (2007) 0.97
Funding of Parkinson research from industry and US federal and foundation sources. Mov Disord (2009) 0.96
Palliative Care Needs in the Neuro-ICU. Crit Care Med (2015) 0.95
Racial differences in mortality among patients with acute ischemic stroke: an observational study. Ann Intern Med (2011) 0.95
Ethics of sham surgery: perspective of patients. Mov Disord (2008) 0.92
Hemicraniectomy for middle-cerebral-artery stroke. N Engl J Med (2014) 0.92
Challenges in assessing hospital-level stroke mortality as a quality measure: comparison of ischemic, intracerebral hemorrhage, and total stroke mortality rates. Stroke (2012) 0.91
Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis. Am J Psychiatry (2003) 0.91
Reading a cost-effectiveness or decision analysis study: Five things to consider. Neurol Clin Pract (2013) 0.90
Variation in do-not-resuscitate orders for patients with ischemic stroke: implications for national hospital comparisons. Stroke (2014) 0.90
Trust in early phase research: therapeutic optimism and protective pessimism. Med Health Care Philos (2008) 0.88
Comparison of enrollees and decliners of Parkinson disease sham surgery trials. Mov Disord (2012) 0.87
Public reporting of quality data for stroke: is it measuring quality? Stroke (2008) 0.85
Parkinson's disease medication use and costs following deep brain stimulation. Mov Disord (2012) 0.84
Biomarkers in Parkinson's disease. Expert Rev Neurother (2006) 0.84
A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy. J Stroke Cerebrovasc Dis (2010) 0.84
Sham surgery controls in Parkinson's disease clinical trials: views of participants. Mov Disord (2012) 0.83
A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia. J Am Geriatr Soc (2007) 0.83
What is the risk of developing parkinsonism following neuroleptic use? Neurology (2006) 0.80
Surrogate endpoints in Parkinson's disease research. Curr Neurol Neurosci Rep (2003) 0.80
Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life. Value Health (2006) 0.80
Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness. Pharmacoeconomics (2005) 0.80
Ethical considerations in stroke patients. Curr Opin Neurol (2014) 0.80
Diffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture? Neurology (2007) 0.80
A review of pramipexole and its clinical utility in Parkinson's disease. Expert Opin Pharmacother (2002) 0.80
Pearls & Oy-sters: a stroke of luck: detecting type A aortic dissection by MRA. Neurology (2011) 0.79
A cost-utility comparison of four first-line medications in painful diabetic neuropathy. Pharmacoeconomics (2008) 0.79
Evidence from cost-effectiveness research. NeuroRx (2004) 0.79
Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial. Med Decis Making (2004) 0.77
Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites. Mov Disord (2014) 0.77
Patient Preferences and Surrogate Decision Making in Neuroscience Intensive Care Units. Neurocrit Care (2015) 0.77
Is it research?: an increasingly common question. Neurology (2010) 0.76
Responsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report. J Neurosurg (2005) 0.76
Could the High Prevalence of Therapeutic Misconception Partly Be a Measurement Problem? IRB (2015) 0.76
Review: noninvasive imaging techniques may be useful for diagnosing 70% to 99% carotid stenosis in symptomatic patients. ACP J Club (2006) 0.75
There is nothing staid about STARD: progress in the reporting of diagnostic accuracy studies. Neurology (2006) 0.75
Too important to fail. Ann Neurol (2013) 0.75
When disclosures are more interesting than the evidence. Stroke (2008) 0.75
Evidence-based neurotherapeutics: a spectrum of evidence. NeuroRx (2004) 0.75
How much is a good night's sleep worth? Stroke (2005) 0.75
Quality of life in epilepsy, multiple sclerosis, and beyond. Ann Neurol (2007) 0.75
Patient and organizational factors related to education and support use by Veterans with Parkinson's disease. Mov Disord (2009) 0.75
Raising the Alarm on Brain Attacks in Surgical Patients: Are We Doing Enough to Prevent and Treat Postoperative Strokes? Anesthesiology (2017) 0.75
Evidence-based research ethics and determinations of "engagement in research". IRB (2014) 0.75